Leukemia Clinical Trials in San Antonio

Showing 1021-1040 of 1,056 trials

A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL)

NCT00073489

The objectives of this study are to evaluate the safety and efficacy of OSI-461 in CLL patients.

Astellas Pharma Inc23 participantsStarted May 2001

Phoenix, Arizona, United States • Aurora, Colorado, United States • Jacksonville, Florida, United States +12 more locations

COMPLETEDPhase 2< 1 mile

Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia

NCT00103844

The primary purpose of this study is to estimate the major cytogenetic response rates of BMS-354825 and imatinib (800 mg/d) in subjects with chronic phase, Philadelphia chromosome positive, chronic myeloid leukemia (PH+ CML) with disease resistant to imatinib at a dose of 400-600 mg/d.

Chronic Myeloid LeukemiaPhiladelphia-Positive Myeloid Leukemia

Bristol-Myers Squibb150 participantsStarted Feb 2005

Birmingham, Alabama, United States • Anaheim, California, United States • Bakersfield, California, United States +128 more locations

A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL)

Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia

Leukemia Trials in Other Cities

Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer

Trial of STAHIST in Seasonal Allergic Rhinitis

Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases

Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.

Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer

Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer

Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors

A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC

Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML

Study of XL281 in Adults With Solid Tumors

STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study

Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide

CPG 7909 Injection in Non-Small Cell Lung Cancer

A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer

Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung Carcinoma

Other Conditions in San Antonio